The end product – the world’s first commercially available rapid diagnostic test for chronic wound care – measured protease enzyme activity via a simple, easy-to-read swab sample.
With the help of the test, clinicians could quickly select the best treatment, transforming the time it takes for wounds to heal, promoting patient wellbeing and enabling significant cost savings for the provider.
“The wound diagnostic has helped us, as clinicians, recognise earlier what treatments to provide to our patients. It is also cost effective because it decreases the frequency of patient visits and product use.”
Specialist wound care nurse, UK hospital.